Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-01-22 | 2021-02-25 | 132254 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2021-01-15 | 2021-02-25 | 131706 |
| TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2021-01-15 | 2021-02-25 | 131703 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-25 | 131084 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-25 | 131063 |
| TEVA-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-05-29 | 2021-02-25 | 116156 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Actual shortage | 2021-02-18 | 2021-02-18 | 134352 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-01-07 | 2021-02-18 | 131075 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2021-01-07 | 2021-02-18 | 131060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-06-25 | 2021-02-18 | 118957 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2021-01-22 | 2021-02-12 | 132294 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Resolved | 2020-12-17 | 2021-02-12 | 130319 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Resolved | 2020-10-30 | 2021-02-12 | 127622 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-12-10 | 2021-02-12 | 129981 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-12 | 131093 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2021-02-12 | 92232 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-22 | 2021-02-12 | 132297 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-02-12 | 132669 |
| ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2021-01-22 | 2021-02-12 | 132291 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2021-02-05 | 2021-02-11 | 133467 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |